We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.235 | -4.94% | 4.52 | 4.35 | 4.69 | 4.75 | 4.36 | 4.75 | 212,429 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.50 | 9.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/8/2020 21:18 | Yeah, but predicting a MC of £40bn at this stage is just blatant ramping, there's no other way to describe it. Even if SNG001 passed trials, a JV or licensing deal was struck with a major pharma and it was approved for use in cases of covid *and* COPD *and* asthma the company *still* wouldn't be worth that much... | sloppyjoe2 | |
23/8/2020 21:10 | Sloppy, ok I will ease off on my predictions but they are not blatant ramping, remember I was the guy who predicted Spirent at 10p, Taylor wimpey at 5p and Vodafone at 62p Wait, watch and see 🚀😉 | strongbuy | |
23/8/2020 21:04 | Yep.https://apple.ne | sloppyjoe2 | |
23/8/2020 21:02 | It's plasma treatment he will be announcing | greenrichard | |
23/8/2020 21:01 | Strongbuy - if it opens at 400p tomorrow I will admit you are a genius. If it *doesn't*, will you lay off the blatant ramping for a while? Your unrealistic 'targets' really don't do anyone any favours... | sloppyjoe2 | |
23/8/2020 20:38 | Fest have you done the 'business' yet ?? | meek voles | |
23/8/2020 20:38 | Well said 👍 | meek voles | |
23/8/2020 20:36 | Sloppy joe is still showing himself up for the plank he is! | dave444 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions